NCT01252056View on ClinicalTrials.gov

A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy

PHASE4CompletedINTERVENTIONAL
Enrollment

353

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Diabetic Nephropathy
Interventions
DRUG

Probucol

250mg,Bid

DRUG

Probucol and Cilostazol

50-100mg,Bid

Trial Locations (1)

Unknown

Beijing Universuty First Hospital, Beijng

Sponsors
All Listed Sponsors
lead

Otsuka Beijing Research Institute

INDUSTRY